🇺🇸 FDA
Patent

US 8022052

Inhibition of PPAR gamma expression by specific osteogenic oxysterols

granted A61KA61K31/57A61P

Quick answer

US patent 8022052 (Inhibition of PPAR gamma expression by specific osteogenic oxysterols) held by The Regents of the University of California expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/57, A61P, A61P3/04